ANTAGONISTES SÉLECTIFS DE NR2B

• 收藏
• 分享

专利权人:

Bristol-Myers Squibb Company

发明人:

申请号：

EP15703328.3

公开号：

EP3092224B1

申请日:

2015.01.06

申请国别(地区):

EP

年份:

2018

代理人:

摘要：

The disclosure generally relates to compounds of formula I, including their salts, as well as compositions and methods of using the compounds. The compounds are ligands of the NR2B receptor and may be useful for the treatment of various disorders of the central nervous system.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/